Press release
Nonerosive Reflux Disease Treatment Market: Outlook, Opportunity and Demand Analysis , Forecast 2018 to 2026
Request Brochure of this Report at https://www.factmr.com/connectus/sample?flag=B&rep_id=1098
50 to 70% patients with GERD and 49% patients with heartburn tend to have nonerosive reflux disease, hence increasing prevalence of GERD and heartburn attributing to growth of nonerosive reflux disease treatment market. Development of GERD, Heartburn and nonerosive reflux disease is correlating to increasing prevalence of obesity and other dietary factors which are driving nonerosive reflux disease treatment market. Consequential impact on health related quality of life along with work related productivity is indicative of more chances to develop NERD which in term driving nonerosive reflux disease treatment market. Various studies have concluded that patients with nonerosive reflux disease have 20 to 30% less chances of getting relief from acid-blocking drugs hence making it difficult to treat nonerosive reflux disease with PPI. Non-availability of efficient treatment acting as a restraint in nonerosive reflux disease treatment market growth. Difficulty in diagnosis of nonerosive reflux disease further makes treatment difficult attributing to low nonerosive reflux disease market growth. Higher doses of proton pump inhibitor drugs are reported to develop adverse events further making nonerosive reflux disease treatment difficult. There is no treatment strategy established for nonerosive reflux disease treatment.
The global nonerosive reflux disease treatment market is classified on the basis of product type, distribution channel and region
Based on the drug type nonerosive reflux disease treatment market is segmented into following:
Proton pump inhibitors
H2 – blockers
Antacids
Prokinetics
Based on the distribution channel nonerosive reflux disease treatment market is segmented into following:
Retail pharmacies
Hospital pharmacies
Online pharmacies
Various studies are going to develop strategy for treatment and diagnosis enhancing growth on nonerosive reflux disease market. Many studies are going on to distinguish nonerosive reflux disease patients from those with erosive esophagitis to make diagnosis and nonerosive reflux disease treatment efficient. Rising clinical studies in nonerosive reflux disease treatment are expected to drive market growth over forecast period. Advanced drug molecule development in proton pump inhibitor class is expected to improve PPI result in nonerosive reflux disease treatment. By drug type proton pump inhibitors segment is most preferred for nonerosive reflux disease treatment. By distribution channel retail pharmacies segment is expected to dominate due high preference. Increased studies to evaluate nonerosive reflux disease diagnosis and treatment is further attributed to drive nonerosive reflux disease treatment market.
On the basis of geography, global nonerosive reflux disease treatment market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Region wise North America is most lucrative market due increased prevalence of gastroesophageal reflux disease (GERD) and heartburn. Health related lifestyle correlating to obesity in North America is responsible for increasing nonerosive reflux disease treatment market and is only expected to grow. Nonerosive reflux disease is most common in patients with GERD and prevalence of gastroesophageal reflux disease (GERD) in North America (20%), Europe (9-17%) Asia Pacific (2-5%) once a week which is further responsible for nonerosive reflux disease treatment.
Request TOC of this Report at https://www.factmr.com/connectus/sample?flag=T&rep_id=1098
Key major players in the nonerosive reflux disease treatment market are: AstraZeneca plc, Eisai Co, GlaxoSmithKline PLC; Takeda Pharmaceutical Co., Ltd, Johnson & Johnson, Daewoong Pharmaceutical Co., Ltd.; Ironwood Pharmaceuticals, Inc.; SRS Pharmaceuticals Pvt. Ltd.; and SFJ Pharmaceuticals Group
The report covers exhaustive analysis on:
Nonerosive reflux disease treatment Market Segments
Nonerosive reflux disease treatment Market Dynamics
Historical Actual Market Size, 2013 - 2017
Nonerosive reflux disease treatment Market Size & Forecast 2018 to 2024
Nonerosive reflux disease treatment Agents Current Trends/Issues/Challenges
Competition & Companies involved
Nonerosive reflux disease treatment Market Drivers and Restraints
Regional analysis includes
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Report Highlights:
Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size recent industry trends
Key Competition landscape
Strategies for key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance
Report Analysis at https://www.factmr.com/report/1098/nonerosive-reflux-disease-treatment-market
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonerosive Reflux Disease Treatment Market: Outlook, Opportunity and Demand Analysis , Forecast 2018 to 2026 here
News-ID: 1218261 • Views: …
More Releases from Fact.MR
Non-Alcoholic Wine Market to Expand at 10% CAGR, Reaching $5.2 Billion by 2033
The global demand for non-alcoholic wine is predicted to grow at a 10% CAGR between 2023 and 2033. The global non-alcoholic wine market is currently valued at $2 billion and is expected to grow to $5.2 billion by 2033.
Increased demand for nonalcoholic wine in Middle Eastern nations like Kuwait and the UAE will drive market expansion. Athletes and pregnant women are the primary consumers of non-alcoholic wine. The health ramifications…
Personal Floatation Devices Market Soars, Expected to Hit US$ 8,014 Million by 2 …
The global personal floatation devices market is expected to be valued at US$ 3,178.7 million in 2022, growing at a CAGR of 9.7% to US$ 8,014 million by the end of 2032.
The personal flotation device market is transitioning from 'distributor-based' sales to direct-to-customer online channels. Catering to the needs of last-mile consumers is a profitable opportunity for manufacturers, and utilising online sales channels can help businesses capitalise on the emerging…
Paper Bottle Market Expected to Expand at 6.2% CAGR by 2033
The Paper Bottles Market is estimated to reach US $ 53.31 million by 2033, with a 6.2% growth rate during the forecast period.
Paper bottle sales are fast increasing, owing to both the growing need for alternatives to plastic bottles and the degradability and eco-friendliness of these containers. Paper bottle sales are expected to rise as demand for beverages rises and effective storage becomes more important.
Get Free Sample Copy of This…
Halloumi Cheese Market Surges Past US$ 1.2 Billion Mark by 2033, Fueled by 10.4% …
It is anticipated that halloumi cheese market will be valued at US$ 445 million in 2023 and surpass US$ 1.2 billion by the end of 2033. It is projected that the worldwide market for halloumi cheese will grow at an astounding rate of 10.4% CAGR till 2033.
Cyprus, a Middle Eastern nation, is the birthplace of halloumi cheese, which has been made there by local farmers for generations. Since this nation…
More Releases for Nonerosive
Nonerosive Reflux Disease Treatment Market 2031 Report Enlightening Development …
The research report presents a market assessment of the Nonerosive Reflux Disease Treatment market and contains thoughtful insights, facts, and historical data and statistically supported and industry-validated market data
It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application and industry
250 page market research report by Fact.MR, ( leading business and competitive intelligence provider),…
Nonerosive Reflux Disease Treatment Market Information, Figures and Analytical I …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
Nonerosive Reflux Disease Treatment Market Shares, Strategies and Forecast World …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
Emerging Opportunities in Nonerosive Reflux Disease Treatment Market with Curren …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
Nonerosive Reflux Disease Treatment Market to Reap Excessive Revenues by 2018 to …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
Nonerosive Reflux Disease Treatment Market Segments, Dynamics, Treatment Agents …
FACT.MR has been actively involved in offering comprehensive research data concerning various topics which are associated to industrial reference and investor utility. This particular research report titled “Nonerosive Reflux Disease Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2026” has been added to the wide online database of FACT.MR which discusses the present as well as future market scenario. Readers can access knowledge related to…
